nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosentan—CYP2C9—Omeprazole—Barrett's esophagus	0.204	0.389	CbGbCtD
Bosentan—CYP3A4—Esomeprazole—Barrett's esophagus	0.201	0.384	CbGbCtD
Bosentan—CYP3A4—Omeprazole—Barrett's esophagus	0.118	0.226	CbGbCtD
Bosentan—ABCB11—bile—Barrett's esophagus	0.0607	0.851	CbGeAlD
Bosentan—Leg edema—Omeprazole—Barrett's esophagus	0.0108	0.0311	CcSEcCtD
Bosentan—Leg edema—Esomeprazole—Barrett's esophagus	0.0108	0.0311	CcSEcCtD
Bosentan—ABCB11—digestive system—Barrett's esophagus	0.00663	0.093	CbGeAlD
Bosentan—ABCB11—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.00653	0.111	CbGpPWpGaD
Bosentan—ABCB11—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.00375	0.0639	CbGpPWpGaD
Bosentan—ABCB11—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.00375	0.0639	CbGpPWpGaD
Bosentan—EDNRB—Endothelins—SLC9A1—Barrett's esophagus	0.00358	0.0609	CbGpPWpGaD
Bosentan—Eye irritation—Esomeprazole—Barrett's esophagus	0.0034	0.0098	CcSEcCtD
Bosentan—Eye irritation—Omeprazole—Barrett's esophagus	0.0034	0.0098	CcSEcCtD
Bosentan—Bone disorder—Omeprazole—Barrett's esophagus	0.00321	0.00927	CcSEcCtD
Bosentan—Gastrooesophageal reflux disease—Omeprazole—Barrett's esophagus	0.00321	0.00927	CcSEcCtD
Bosentan—Bone disorder—Esomeprazole—Barrett's esophagus	0.00321	0.00927	CcSEcCtD
Bosentan—Gastrooesophageal reflux disease—Esomeprazole—Barrett's esophagus	0.00321	0.00927	CcSEcCtD
Bosentan—Cystitis noninfective—Esomeprazole—Barrett's esophagus	0.00283	0.00818	CcSEcCtD
Bosentan—Cystitis noninfective—Omeprazole—Barrett's esophagus	0.00283	0.00818	CcSEcCtD
Bosentan—Cystitis—Omeprazole—Barrett's esophagus	0.0028	0.00808	CcSEcCtD
Bosentan—Cystitis—Esomeprazole—Barrett's esophagus	0.0028	0.00808	CcSEcCtD
Bosentan—Fluid retention—Esomeprazole—Barrett's esophagus	0.00275	0.00795	CcSEcCtD
Bosentan—Fluid retention—Omeprazole—Barrett's esophagus	0.00275	0.00795	CcSEcCtD
Bosentan—Mouth ulceration—Omeprazole—Barrett's esophagus	0.00262	0.00757	CcSEcCtD
Bosentan—Bladder pain—Omeprazole—Barrett's esophagus	0.00262	0.00757	CcSEcCtD
Bosentan—Mouth ulceration—Esomeprazole—Barrett's esophagus	0.00262	0.00757	CcSEcCtD
Bosentan—Bladder pain—Esomeprazole—Barrett's esophagus	0.00262	0.00757	CcSEcCtD
Bosentan—EDNRA—Endothelins—SLC9A1—Barrett's esophagus	0.00256	0.0436	CbGpPWpGaD
Bosentan—Blood alkaline phosphatase increased—Esomeprazole—Barrett's esophagus	0.00242	0.00699	CcSEcCtD
Bosentan—Blood alkaline phosphatase increased—Omeprazole—Barrett's esophagus	0.00242	0.00699	CcSEcCtD
Bosentan—Hepatic function abnormal—Omeprazole—Barrett's esophagus	0.00241	0.00695	CcSEcCtD
Bosentan—Hepatic function abnormal—Esomeprazole—Barrett's esophagus	0.00241	0.00695	CcSEcCtD
Bosentan—Gastroenteritis—Esomeprazole—Barrett's esophagus	0.00238	0.00686	CcSEcCtD
Bosentan—Gastroenteritis—Omeprazole—Barrett's esophagus	0.00238	0.00686	CcSEcCtD
Bosentan—Hepatic failure—Omeprazole—Barrett's esophagus	0.00234	0.00676	CcSEcCtD
Bosentan—Hepatic failure—Esomeprazole—Barrett's esophagus	0.00234	0.00676	CcSEcCtD
Bosentan—EDNRB—Prostaglandin Synthesis and Regulation—PTGS2—Barrett's esophagus	0.00233	0.0396	CbGpPWpGaD
Bosentan—CYP2C9—digestive system—Barrett's esophagus	0.00225	0.0315	CbGeAlD
Bosentan—Thirst—Omeprazole—Barrett's esophagus	0.00221	0.00638	CcSEcCtD
Bosentan—Renal impairment—Esomeprazole—Barrett's esophagus	0.00221	0.00638	CcSEcCtD
Bosentan—Thirst—Esomeprazole—Barrett's esophagus	0.00221	0.00638	CcSEcCtD
Bosentan—Renal impairment—Omeprazole—Barrett's esophagus	0.00221	0.00638	CcSEcCtD
Bosentan—Hypoglycaemia—Esomeprazole—Barrett's esophagus	0.00216	0.00623	CcSEcCtD
Bosentan—Hypoglycaemia—Omeprazole—Barrett's esophagus	0.00216	0.00623	CcSEcCtD
Bosentan—Hyponatraemia—Esomeprazole—Barrett's esophagus	0.00211	0.0061	CcSEcCtD
Bosentan—Hyponatraemia—Omeprazole—Barrett's esophagus	0.00211	0.0061	CcSEcCtD
Bosentan—Pain in extremity—Omeprazole—Barrett's esophagus	0.00211	0.00608	CcSEcCtD
Bosentan—Pain in extremity—Esomeprazole—Barrett's esophagus	0.00211	0.00608	CcSEcCtD
Bosentan—Irritability—Esomeprazole—Barrett's esophagus	0.00201	0.0058	CcSEcCtD
Bosentan—Irritability—Omeprazole—Barrett's esophagus	0.00201	0.0058	CcSEcCtD
Bosentan—EDNRB—G alpha (q) signalling events—GAST—Barrett's esophagus	0.00196	0.0333	CbGpPWpGaD
Bosentan—Dry skin—Omeprazole—Barrett's esophagus	0.00193	0.00557	CcSEcCtD
Bosentan—Dry skin—Esomeprazole—Barrett's esophagus	0.00193	0.00557	CcSEcCtD
Bosentan—Abdominal pain upper—Esomeprazole—Barrett's esophagus	0.00192	0.00555	CcSEcCtD
Bosentan—Abdominal pain upper—Omeprazole—Barrett's esophagus	0.00192	0.00555	CcSEcCtD
Bosentan—Hypokalaemia—Esomeprazole—Barrett's esophagus	0.00192	0.00553	CcSEcCtD
Bosentan—Hypokalaemia—Omeprazole—Barrett's esophagus	0.00192	0.00553	CcSEcCtD
Bosentan—Cramp muscle—Esomeprazole—Barrett's esophagus	0.0019	0.00547	CcSEcCtD
Bosentan—Cramp muscle—Omeprazole—Barrett's esophagus	0.0019	0.00547	CcSEcCtD
Bosentan—Abdominal distension—Omeprazole—Barrett's esophagus	0.00183	0.00529	CcSEcCtD
Bosentan—Abdominal distension—Esomeprazole—Barrett's esophagus	0.00183	0.00529	CcSEcCtD
Bosentan—Influenza—Esomeprazole—Barrett's esophagus	0.00182	0.00525	CcSEcCtD
Bosentan—Asthma—Esomeprazole—Barrett's esophagus	0.00182	0.00525	CcSEcCtD
Bosentan—Influenza—Omeprazole—Barrett's esophagus	0.00182	0.00525	CcSEcCtD
Bosentan—Asthma—Omeprazole—Barrett's esophagus	0.00182	0.00525	CcSEcCtD
Bosentan—Bronchospasm—Omeprazole—Barrett's esophagus	0.00179	0.00517	CcSEcCtD
Bosentan—Bronchospasm—Esomeprazole—Barrett's esophagus	0.00179	0.00517	CcSEcCtD
Bosentan—Sweating increased—Esomeprazole—Barrett's esophagus	0.00177	0.00512	CcSEcCtD
Bosentan—Angina pectoris—Esomeprazole—Barrett's esophagus	0.00177	0.00512	CcSEcCtD
Bosentan—Sweating increased—Omeprazole—Barrett's esophagus	0.00177	0.00512	CcSEcCtD
Bosentan—Angina pectoris—Omeprazole—Barrett's esophagus	0.00177	0.00512	CcSEcCtD
Bosentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—Barrett's esophagus	0.00175	0.0298	CbGpPWpGaD
Bosentan—CYP3A4—digestive system—Barrett's esophagus	0.00171	0.024	CbGeAlD
Bosentan—Neutropenia—Omeprazole—Barrett's esophagus	0.0017	0.00491	CcSEcCtD
Bosentan—Dysuria—Esomeprazole—Barrett's esophagus	0.0017	0.00491	CcSEcCtD
Bosentan—Dysuria—Omeprazole—Barrett's esophagus	0.0017	0.00491	CcSEcCtD
Bosentan—Neutropenia—Esomeprazole—Barrett's esophagus	0.0017	0.00491	CcSEcCtD
Bosentan—Upper respiratory tract infection—Omeprazole—Barrett's esophagus	0.00169	0.00488	CcSEcCtD
Bosentan—Upper respiratory tract infection—Esomeprazole—Barrett's esophagus	0.00169	0.00488	CcSEcCtD
Bosentan—Pollakiuria—Omeprazole—Barrett's esophagus	0.00168	0.00485	CcSEcCtD
Bosentan—Pollakiuria—Esomeprazole—Barrett's esophagus	0.00168	0.00485	CcSEcCtD
Bosentan—EDNRA—Prostaglandin Synthesis and Regulation—PTGS2—Barrett's esophagus	0.00167	0.0284	CbGpPWpGaD
Bosentan—Weight increased—Omeprazole—Barrett's esophagus	0.00166	0.00478	CcSEcCtD
Bosentan—Weight increased—Esomeprazole—Barrett's esophagus	0.00166	0.00478	CcSEcCtD
Bosentan—Weight decreased—Omeprazole—Barrett's esophagus	0.00165	0.00475	CcSEcCtD
Bosentan—Weight decreased—Esomeprazole—Barrett's esophagus	0.00165	0.00475	CcSEcCtD
Bosentan—Infestation—Omeprazole—Barrett's esophagus	0.00162	0.00468	CcSEcCtD
Bosentan—Infestation—Esomeprazole—Barrett's esophagus	0.00162	0.00468	CcSEcCtD
Bosentan—Infestation NOS—Esomeprazole—Barrett's esophagus	0.00162	0.00468	CcSEcCtD
Bosentan—Infestation NOS—Omeprazole—Barrett's esophagus	0.00162	0.00468	CcSEcCtD
Bosentan—Stevens-Johnson syndrome—Omeprazole—Barrett's esophagus	0.00161	0.00464	CcSEcCtD
Bosentan—Stevens-Johnson syndrome—Esomeprazole—Barrett's esophagus	0.00161	0.00464	CcSEcCtD
Bosentan—Renal failure—Esomeprazole—Barrett's esophagus	0.0016	0.0046	CcSEcCtD
Bosentan—Renal failure—Omeprazole—Barrett's esophagus	0.0016	0.0046	CcSEcCtD
Bosentan—Stomatitis—Esomeprazole—Barrett's esophagus	0.00158	0.00456	CcSEcCtD
Bosentan—Jaundice—Esomeprazole—Barrett's esophagus	0.00158	0.00456	CcSEcCtD
Bosentan—Jaundice—Omeprazole—Barrett's esophagus	0.00158	0.00456	CcSEcCtD
Bosentan—Stomatitis—Omeprazole—Barrett's esophagus	0.00158	0.00456	CcSEcCtD
Bosentan—Conjunctivitis—Esomeprazole—Barrett's esophagus	0.00158	0.00455	CcSEcCtD
Bosentan—Urinary tract infection—Esomeprazole—Barrett's esophagus	0.00158	0.00455	CcSEcCtD
Bosentan—Conjunctivitis—Omeprazole—Barrett's esophagus	0.00158	0.00455	CcSEcCtD
Bosentan—Urinary tract infection—Omeprazole—Barrett's esophagus	0.00158	0.00455	CcSEcCtD
Bosentan—Haematuria—Esomeprazole—Barrett's esophagus	0.00155	0.00446	CcSEcCtD
Bosentan—Haematuria—Omeprazole—Barrett's esophagus	0.00155	0.00446	CcSEcCtD
Bosentan—Hepatobiliary disease—Omeprazole—Barrett's esophagus	0.00154	0.00443	CcSEcCtD
Bosentan—Hepatobiliary disease—Esomeprazole—Barrett's esophagus	0.00154	0.00443	CcSEcCtD
Bosentan—Epistaxis—Esomeprazole—Barrett's esophagus	0.00153	0.00442	CcSEcCtD
Bosentan—Epistaxis—Omeprazole—Barrett's esophagus	0.00153	0.00442	CcSEcCtD
Bosentan—Sinusitis—Esomeprazole—Barrett's esophagus	0.00152	0.00439	CcSEcCtD
Bosentan—Sinusitis—Omeprazole—Barrett's esophagus	0.00152	0.00439	CcSEcCtD
Bosentan—Bradycardia—Omeprazole—Barrett's esophagus	0.00148	0.00428	CcSEcCtD
Bosentan—Bradycardia—Esomeprazole—Barrett's esophagus	0.00148	0.00428	CcSEcCtD
Bosentan—Hepatitis—Omeprazole—Barrett's esophagus	0.00146	0.0042	CcSEcCtD
Bosentan—Hepatitis—Esomeprazole—Barrett's esophagus	0.00146	0.0042	CcSEcCtD
Bosentan—Hypoaesthesia—Omeprazole—Barrett's esophagus	0.00145	0.00418	CcSEcCtD
Bosentan—Hypoaesthesia—Esomeprazole—Barrett's esophagus	0.00145	0.00418	CcSEcCtD
Bosentan—Urinary tract disorder—Omeprazole—Barrett's esophagus	0.00144	0.00415	CcSEcCtD
Bosentan—Urinary tract disorder—Esomeprazole—Barrett's esophagus	0.00144	0.00415	CcSEcCtD
Bosentan—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.00144	0.0245	CbGpPWpGaD
Bosentan—Oedema peripheral—Esomeprazole—Barrett's esophagus	0.00144	0.00414	CcSEcCtD
Bosentan—Oedema peripheral—Omeprazole—Barrett's esophagus	0.00144	0.00414	CcSEcCtD
Bosentan—Urethral disorder—Esomeprazole—Barrett's esophagus	0.00143	0.00412	CcSEcCtD
Bosentan—Urethral disorder—Omeprazole—Barrett's esophagus	0.00143	0.00412	CcSEcCtD
Bosentan—EDNRA—G alpha (q) signalling events—GAST—Barrett's esophagus	0.0014	0.0238	CbGpPWpGaD
Bosentan—Erythema multiforme—Omeprazole—Barrett's esophagus	0.00138	0.00397	CcSEcCtD
Bosentan—Erythema multiforme—Esomeprazole—Barrett's esophagus	0.00138	0.00397	CcSEcCtD
Bosentan—Eye disorder—Omeprazole—Barrett's esophagus	0.00136	0.00393	CcSEcCtD
Bosentan—Eye disorder—Esomeprazole—Barrett's esophagus	0.00136	0.00393	CcSEcCtD
Bosentan—Tinnitus—Esomeprazole—Barrett's esophagus	0.00136	0.00392	CcSEcCtD
Bosentan—Tinnitus—Omeprazole—Barrett's esophagus	0.00136	0.00392	CcSEcCtD
Bosentan—Flushing—Esomeprazole—Barrett's esophagus	0.00135	0.0039	CcSEcCtD
Bosentan—Flushing—Omeprazole—Barrett's esophagus	0.00135	0.0039	CcSEcCtD
Bosentan—EDNRB—Peptide ligand-binding receptors—SST—Barrett's esophagus	0.00132	0.0225	CbGpPWpGaD
Bosentan—Immune system disorder—Omeprazole—Barrett's esophagus	0.00132	0.0038	CcSEcCtD
Bosentan—Immune system disorder—Esomeprazole—Barrett's esophagus	0.00132	0.0038	CcSEcCtD
Bosentan—Mediastinal disorder—Esomeprazole—Barrett's esophagus	0.00131	0.00379	CcSEcCtD
Bosentan—Mediastinal disorder—Omeprazole—Barrett's esophagus	0.00131	0.00379	CcSEcCtD
Bosentan—Chills—Omeprazole—Barrett's esophagus	0.00131	0.00377	CcSEcCtD
Bosentan—Chills—Esomeprazole—Barrett's esophagus	0.00131	0.00377	CcSEcCtD
Bosentan—Mental disorder—Esomeprazole—Barrett's esophagus	0.00128	0.00368	CcSEcCtD
Bosentan—Mental disorder—Omeprazole—Barrett's esophagus	0.00128	0.00368	CcSEcCtD
Bosentan—Malnutrition—Omeprazole—Barrett's esophagus	0.00127	0.00366	CcSEcCtD
Bosentan—Malnutrition—Esomeprazole—Barrett's esophagus	0.00127	0.00366	CcSEcCtD
Bosentan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.00125	0.0213	CbGpPWpGaD
Bosentan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.00125	0.0213	CbGpPWpGaD
Bosentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—Barrett's esophagus	0.00125	0.0213	CbGpPWpGaD
Bosentan—Flatulence—Omeprazole—Barrett's esophagus	0.00125	0.00361	CcSEcCtD
Bosentan—Flatulence—Esomeprazole—Barrett's esophagus	0.00125	0.00361	CcSEcCtD
Bosentan—ABCB11—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.00123	0.021	CbGpPWpGaD
Bosentan—Back pain—Esomeprazole—Barrett's esophagus	0.00123	0.00354	CcSEcCtD
Bosentan—Back pain—Omeprazole—Barrett's esophagus	0.00123	0.00354	CcSEcCtD
Bosentan—Muscle spasms—Omeprazole—Barrett's esophagus	0.00122	0.00352	CcSEcCtD
Bosentan—Muscle spasms—Esomeprazole—Barrett's esophagus	0.00122	0.00352	CcSEcCtD
Bosentan—CYP2C9—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.00121	0.0207	CbGpPWpGaD
Bosentan—Vision blurred—Esomeprazole—Barrett's esophagus	0.0012	0.00345	CcSEcCtD
Bosentan—Vision blurred—Omeprazole—Barrett's esophagus	0.0012	0.00345	CcSEcCtD
Bosentan—Tremor—Esomeprazole—Barrett's esophagus	0.00119	0.00343	CcSEcCtD
Bosentan—Tremor—Omeprazole—Barrett's esophagus	0.00119	0.00343	CcSEcCtD
Bosentan—Anaemia—Esomeprazole—Barrett's esophagus	0.00117	0.00338	CcSEcCtD
Bosentan—Anaemia—Omeprazole—Barrett's esophagus	0.00117	0.00338	CcSEcCtD
Bosentan—Angioedema—Esomeprazole—Barrett's esophagus	0.00116	0.00334	CcSEcCtD
Bosentan—Angioedema—Omeprazole—Barrett's esophagus	0.00116	0.00334	CcSEcCtD
Bosentan—Vertigo—Omeprazole—Barrett's esophagus	0.00114	0.00329	CcSEcCtD
Bosentan—Vertigo—Esomeprazole—Barrett's esophagus	0.00114	0.00329	CcSEcCtD
Bosentan—Leukopenia—Omeprazole—Barrett's esophagus	0.00114	0.00328	CcSEcCtD
Bosentan—Leukopenia—Esomeprazole—Barrett's esophagus	0.00114	0.00328	CcSEcCtD
Bosentan—Palpitations—Esomeprazole—Barrett's esophagus	0.00112	0.00323	CcSEcCtD
Bosentan—Palpitations—Omeprazole—Barrett's esophagus	0.00112	0.00323	CcSEcCtD
Bosentan—Cough—Esomeprazole—Barrett's esophagus	0.00111	0.00319	CcSEcCtD
Bosentan—Cough—Omeprazole—Barrett's esophagus	0.00111	0.00319	CcSEcCtD
Bosentan—Chest pain—Esomeprazole—Barrett's esophagus	0.00108	0.00312	CcSEcCtD
Bosentan—Arthralgia—Omeprazole—Barrett's esophagus	0.00108	0.00312	CcSEcCtD
Bosentan—Chest pain—Omeprazole—Barrett's esophagus	0.00108	0.00312	CcSEcCtD
Bosentan—Arthralgia—Esomeprazole—Barrett's esophagus	0.00108	0.00312	CcSEcCtD
Bosentan—Anxiety—Omeprazole—Barrett's esophagus	0.00108	0.0031	CcSEcCtD
Bosentan—Anxiety—Esomeprazole—Barrett's esophagus	0.00108	0.0031	CcSEcCtD
Bosentan—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.00107	0.00309	CcSEcCtD
Bosentan—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.00107	0.00309	CcSEcCtD
Bosentan—Discomfort—Esomeprazole—Barrett's esophagus	0.00107	0.00308	CcSEcCtD
Bosentan—Discomfort—Omeprazole—Barrett's esophagus	0.00107	0.00308	CcSEcCtD
Bosentan—Dry mouth—Omeprazole—Barrett's esophagus	0.00106	0.00305	CcSEcCtD
Bosentan—Dry mouth—Esomeprazole—Barrett's esophagus	0.00106	0.00305	CcSEcCtD
Bosentan—Anaphylactic shock—Omeprazole—Barrett's esophagus	0.00104	0.00299	CcSEcCtD
Bosentan—Anaphylactic shock—Esomeprazole—Barrett's esophagus	0.00104	0.00299	CcSEcCtD
Bosentan—Infection—Esomeprazole—Barrett's esophagus	0.00103	0.00297	CcSEcCtD
Bosentan—Infection—Omeprazole—Barrett's esophagus	0.00103	0.00297	CcSEcCtD
Bosentan—Shock—Esomeprazole—Barrett's esophagus	0.00102	0.00294	CcSEcCtD
Bosentan—Shock—Omeprazole—Barrett's esophagus	0.00102	0.00294	CcSEcCtD
Bosentan—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.00102	0.00293	CcSEcCtD
Bosentan—Nervous system disorder—Omeprazole—Barrett's esophagus	0.00102	0.00293	CcSEcCtD
Bosentan—Thrombocytopenia—Esomeprazole—Barrett's esophagus	0.00101	0.00292	CcSEcCtD
Bosentan—Thrombocytopenia—Omeprazole—Barrett's esophagus	0.00101	0.00292	CcSEcCtD
Bosentan—Tachycardia—Omeprazole—Barrett's esophagus	0.00101	0.00291	CcSEcCtD
Bosentan—Tachycardia—Esomeprazole—Barrett's esophagus	0.00101	0.00291	CcSEcCtD
Bosentan—Skin disorder—Omeprazole—Barrett's esophagus	0.00101	0.0029	CcSEcCtD
Bosentan—Skin disorder—Esomeprazole—Barrett's esophagus	0.00101	0.0029	CcSEcCtD
Bosentan—Hyperhidrosis—Omeprazole—Barrett's esophagus	0.001	0.00289	CcSEcCtD
Bosentan—Hyperhidrosis—Esomeprazole—Barrett's esophagus	0.001	0.00289	CcSEcCtD
Bosentan—Anorexia—Omeprazole—Barrett's esophagus	0.000987	0.00285	CcSEcCtD
Bosentan—Anorexia—Esomeprazole—Barrett's esophagus	0.000987	0.00285	CcSEcCtD
Bosentan—EDNRA—Peptide ligand-binding receptors—SST—Barrett's esophagus	0.000947	0.0161	CbGpPWpGaD
Bosentan—Musculoskeletal discomfort—Omeprazole—Barrett's esophagus	0.000943	0.00272	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Esomeprazole—Barrett's esophagus	0.000943	0.00272	CcSEcCtD
Bosentan—Insomnia—Omeprazole—Barrett's esophagus	0.000936	0.0027	CcSEcCtD
Bosentan—Insomnia—Esomeprazole—Barrett's esophagus	0.000936	0.0027	CcSEcCtD
Bosentan—Paraesthesia—Esomeprazole—Barrett's esophagus	0.00093	0.00268	CcSEcCtD
Bosentan—Paraesthesia—Omeprazole—Barrett's esophagus	0.00093	0.00268	CcSEcCtD
Bosentan—Dyspnoea—Omeprazole—Barrett's esophagus	0.000923	0.00266	CcSEcCtD
Bosentan—Dyspnoea—Esomeprazole—Barrett's esophagus	0.000923	0.00266	CcSEcCtD
Bosentan—Somnolence—Omeprazole—Barrett's esophagus	0.00092	0.00265	CcSEcCtD
Bosentan—Somnolence—Esomeprazole—Barrett's esophagus	0.00092	0.00265	CcSEcCtD
Bosentan—Dyspepsia—Esomeprazole—Barrett's esophagus	0.000911	0.00263	CcSEcCtD
Bosentan—Dyspepsia—Omeprazole—Barrett's esophagus	0.000911	0.00263	CcSEcCtD
Bosentan—Decreased appetite—Esomeprazole—Barrett's esophagus	0.0009	0.0026	CcSEcCtD
Bosentan—Decreased appetite—Omeprazole—Barrett's esophagus	0.0009	0.0026	CcSEcCtD
Bosentan—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.000894	0.00258	CcSEcCtD
Bosentan—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.000894	0.00258	CcSEcCtD
Bosentan—Fatigue—Omeprazole—Barrett's esophagus	0.000892	0.00257	CcSEcCtD
Bosentan—Fatigue—Esomeprazole—Barrett's esophagus	0.000892	0.00257	CcSEcCtD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.000888	0.0151	CbGpPWpGaD
Bosentan—Pain—Omeprazole—Barrett's esophagus	0.000885	0.00255	CcSEcCtD
Bosentan—Constipation—Omeprazole—Barrett's esophagus	0.000885	0.00255	CcSEcCtD
Bosentan—Pain—Esomeprazole—Barrett's esophagus	0.000885	0.00255	CcSEcCtD
Bosentan—Constipation—Esomeprazole—Barrett's esophagus	0.000885	0.00255	CcSEcCtD
Bosentan—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.000846	0.00244	CcSEcCtD
Bosentan—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.000846	0.00244	CcSEcCtD
Bosentan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000826	0.0141	CbGpPWpGaD
Bosentan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000826	0.0141	CbGpPWpGaD
Bosentan—Urticaria—Omeprazole—Barrett's esophagus	0.000822	0.00237	CcSEcCtD
Bosentan—Urticaria—Esomeprazole—Barrett's esophagus	0.000822	0.00237	CcSEcCtD
Bosentan—Body temperature increased—Esomeprazole—Barrett's esophagus	0.000818	0.00236	CcSEcCtD
Bosentan—Abdominal pain—Omeprazole—Barrett's esophagus	0.000818	0.00236	CcSEcCtD
Bosentan—Body temperature increased—Omeprazole—Barrett's esophagus	0.000818	0.00236	CcSEcCtD
Bosentan—Abdominal pain—Esomeprazole—Barrett's esophagus	0.000818	0.00236	CcSEcCtD
Bosentan—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000795	0.0135	CbGpPWpGaD
Bosentan—CYP2C9—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000785	0.0134	CbGpPWpGaD
Bosentan—Hypersensitivity—Omeprazole—Barrett's esophagus	0.000763	0.0022	CcSEcCtD
Bosentan—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.000763	0.0022	CcSEcCtD
Bosentan—Asthenia—Esomeprazole—Barrett's esophagus	0.000743	0.00214	CcSEcCtD
Bosentan—Asthenia—Omeprazole—Barrett's esophagus	0.000743	0.00214	CcSEcCtD
Bosentan—Pruritus—Esomeprazole—Barrett's esophagus	0.000732	0.00211	CcSEcCtD
Bosentan—Pruritus—Omeprazole—Barrett's esophagus	0.000732	0.00211	CcSEcCtD
Bosentan—Diarrhoea—Esomeprazole—Barrett's esophagus	0.000708	0.00204	CcSEcCtD
Bosentan—Diarrhoea—Omeprazole—Barrett's esophagus	0.000708	0.00204	CcSEcCtD
Bosentan—Dizziness—Esomeprazole—Barrett's esophagus	0.000685	0.00197	CcSEcCtD
Bosentan—Dizziness—Omeprazole—Barrett's esophagus	0.000685	0.00197	CcSEcCtD
Bosentan—EDNRB—GPCR ligand binding—SST—Barrett's esophagus	0.000676	0.0115	CbGpPWpGaD
Bosentan—Vomiting—Omeprazole—Barrett's esophagus	0.000658	0.0019	CcSEcCtD
Bosentan—Vomiting—Esomeprazole—Barrett's esophagus	0.000658	0.0019	CcSEcCtD
Bosentan—Rash—Esomeprazole—Barrett's esophagus	0.000653	0.00188	CcSEcCtD
Bosentan—Rash—Omeprazole—Barrett's esophagus	0.000653	0.00188	CcSEcCtD
Bosentan—Dermatitis—Esomeprazole—Barrett's esophagus	0.000652	0.00188	CcSEcCtD
Bosentan—Dermatitis—Omeprazole—Barrett's esophagus	0.000652	0.00188	CcSEcCtD
Bosentan—Headache—Omeprazole—Barrett's esophagus	0.000648	0.00187	CcSEcCtD
Bosentan—Headache—Esomeprazole—Barrett's esophagus	0.000648	0.00187	CcSEcCtD
Bosentan—CYP2C9—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000645	0.011	CbGpPWpGaD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.000635	0.0108	CbGpPWpGaD
Bosentan—Nausea—Omeprazole—Barrett's esophagus	0.000615	0.00177	CcSEcCtD
Bosentan—Nausea—Esomeprazole—Barrett's esophagus	0.000615	0.00177	CcSEcCtD
Bosentan—CYP3A4—Irinotecan Pathway—APC—Barrett's esophagus	0.000573	0.00975	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—GAST—Barrett's esophagus	0.000557	0.00949	CbGpPWpGaD
Bosentan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000524	0.00893	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.00052	0.00885	CbGpPWpGaD
Bosentan—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000518	0.00881	CbGpPWpGaD
Bosentan—EDNRB—Peptide ligand-binding receptors—CXCL8—Barrett's esophagus	0.000516	0.00878	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—GAST—Barrett's esophagus	0.000506	0.00862	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—SST—Barrett's esophagus	0.000484	0.00824	CbGpPWpGaD
Bosentan—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000425	0.00724	CbGpPWpGaD
Bosentan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000412	0.00702	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—GAST—Barrett's esophagus	0.000399	0.00679	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—SST—Barrett's esophagus	0.000382	0.0065	CbGpPWpGaD
Bosentan—EDNRA—Peptide ligand-binding receptors—CXCL8—Barrett's esophagus	0.000369	0.00628	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—GAST—Barrett's esophagus	0.000362	0.00617	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—SST—Barrett's esophagus	0.000347	0.00591	CbGpPWpGaD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	0.000346	0.00589	CbGpPWpGaD
Bosentan—CYP2C9—Biological oxidations—CYP26A1—Barrett's esophagus	0.000342	0.00583	CbGpPWpGaD
Bosentan—CYP2C9—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000338	0.00575	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—GAST—Barrett's esophagus	0.000299	0.00509	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—SST—Barrett's esophagus	0.000273	0.00465	CbGpPWpGaD
Bosentan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000272	0.00463	CbGpPWpGaD
Bosentan—EDNRB—GPCR ligand binding—CXCL8—Barrett's esophagus	0.000263	0.00448	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—SST—Barrett's esophagus	0.000248	0.00423	CbGpPWpGaD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	0.000248	0.00421	CbGpPWpGaD
Bosentan—CYP2C9—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.000238	0.00405	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PTGES—Barrett's esophagus	0.000231	0.00394	CbGpPWpGaD
Bosentan—CYP3A4—Biological oxidations—CYP26A1—Barrett's esophagus	0.000226	0.00384	CbGpPWpGaD
Bosentan—CYP3A4—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000223	0.00379	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—GAST—Barrett's esophagus	0.000214	0.00364	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—SST—Barrett's esophagus	0.000205	0.00349	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—CXCL8—Barrett's esophagus	0.000189	0.00321	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—CYP26A1—Barrett's esophagus	0.000175	0.00299	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000174	0.00295	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—CXCL8—Barrett's esophagus	0.000149	0.00253	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—SST—Barrett's esophagus	0.000147	0.0025	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—CXCL8—Barrett's esophagus	0.000135	0.0023	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	0.00013	0.00221	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—SLC9A1—Barrett's esophagus	0.000126	0.00215	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—APC—Barrett's esophagus	0.000108	0.00185	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—CXCL8—Barrett's esophagus	0.000107	0.00181	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	0.000102	0.00174	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—CXCL8—Barrett's esophagus	9.67e-05	0.00165	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—RELA—Barrett's esophagus	8.47e-05	0.00144	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CXCL8—Barrett's esophagus	7.98e-05	0.00136	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—APC—Barrett's esophagus	7.76e-05	0.00132	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PTGES—Barrett's esophagus	7.73e-05	0.00132	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—RELA—Barrett's esophagus	6.06e-05	0.00103	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CYP26A1—Barrett's esophagus	5.86e-05	0.000997	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PPARG—Barrett's esophagus	5.77e-05	0.000982	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CXCL8—Barrett's esophagus	5.71e-05	0.000973	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PTGES—Barrett's esophagus	5.1e-05	0.000867	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—TP53—Barrett's esophagus	4.9e-05	0.000834	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PTGS2—Barrett's esophagus	4.54e-05	0.000773	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	4.33e-05	0.000737	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—SLC9A1—Barrett's esophagus	4.22e-05	0.000719	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CYP26A1—Barrett's esophagus	3.86e-05	0.000657	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—TP53—Barrett's esophagus	3.51e-05	0.000597	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	3.4e-05	0.000579	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—SLC9A1—Barrett's esophagus	2.78e-05	0.000474	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PPARG—Barrett's esophagus	1.93e-05	0.000328	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PTGS2—Barrett's esophagus	1.52e-05	0.000258	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PPARG—Barrett's esophagus	1.27e-05	0.000216	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PTGS2—Barrett's esophagus	1e-05	0.00017	CbGpPWpGaD
